Riskpilot← Back to searchSign inGet full accessEmiliakliniken AB
ABActiveOrg 5592929201Öster Mälarstrands Allé 112Business and other management consultancy activities · NACE 7020Est. 20201 employees
Revenue 2024
SEK 0
EBITDA margin
—
-293% vs 2023
Equity ratio
54.8%
Financial strength
Net profit 2024
SEK -26K
-423% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -36K | -293% |
| Net profit | SEK -26K | -423% |
| Total assets | SEK 87K | -23% |
| Equity | SEK 48K | -35% |
| Employees | 1 | — |
Legal name
Emiliakliniken AB
Org number
5592929201
Legal form
Aktiebolag
NACE code
7020 · Business and other management consultancy activities
Founded
21 december 2020
Share capital
SEK 25 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Verksamhetens fokus är utveckling, implementering och utbildning inom området hälso- och välfärdsteknik, samt applikationsutveckling inom vårdsektorn. Vidare ska verksamheten utbilda företag och privatpersoner i hälsorelaterade beteenden samt erbjuda hälsorelaterad konsultverksamhet till både företag och privatpersoner.
Address
Öster Mälarstrands Allé 112
Email
johan.ulff@outlook.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 229 | 87 | 64 | 0 |
| Staff expenses | — | −29 | −18 | −2 |
| EBITDA | 94 | −8 | −9 | −36 |
| Depreciation & amort. | −0 | — | — | — |
| EBIT | 94 | −8 | −9 | −36 |
| Net financials | — | −0 | 0 | 0 |
| Profit before tax | 70 | 2 | −5 | −26 |
| Tax | −16 | −2 | — | −0 |
| Net profit | 54 | 0 | −5 | −26 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 297 | 138 | 113 | 87 |
| Equity | 79 | 79 | 74 | 48 |
| Long-term debt | 0 | — | — | — |
| Short-term debt | 194 | 46 | 30 | 39 |
| Total debt | 194 | 46 | 30 | 39 |
EBITDA margin
-3600400.0%
This company
15.8%
Market median
-22787442% vs market
20212024
Equity ratio
54.8%
This company
38.2%
Market median
+43% vs market
20212024
Return on equity
-54.8%
This company
18.4%
Market median
-398% vs market
20212024
Net profit margin
-2618000.0%
This company
8.1%
Market median
-32321088% vs market
20212024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212024
Debt / equity
0.83×
This company
0.62×
Market median
+34% vs market
20212024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-12-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JF Chief Executive Officer | Chief Executive Officer | 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2021 | |
| Deputy Board Member | 2025 | |
| Deputy Board Member | 2021 | |
| Former (1) | ||
| Deputy Board Member | 2021 – 2023 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Emiliakliniken AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Johan Fredrik Claesson Ulff | Chief Executive Officer | 0 companies |
| Anna Charlotta Ulff | Chairman | 0 companies |
| Jan Adam Brangefält | Deputy Board Member | 0 companies |
| Vera Louise Ulff | Deputy Board Member | 0 companies |
| Emilia Charlotta Brangefält | Deputy Board Member | 0 companies |